Eotaxin and eosinophil recruitment: implications for human disease

Kay, 1991, Asthma and inflammation, J. Allergy Clin. Immunol., 87, 893, 10.1016/0091-6749(91)90408-G Giembycz, 1999, Pharmacology of the eosinophil, Pharmacol. Rev., 51, 213 Lefort, 1996, In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitised guinea pigs, J. Clin. Invest., 97, 1117, 10.1172/JCI118505 Collins, 1995, Co-operation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, J. Exp. Med., 182, 1169, 10.1084/jem.182.4.1169 Humbles, 1997, Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo., J. Exp. Med., 186, 601, 10.1084/jem.186.4.601 Palframan, 1998, Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase, J. Exp. Med., 188, 1621, 10.1084/jem.188.9.1621 Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm, Cell, 76, 301, 10.1016/0092-8674(94)90337-9 Bochner, 1995, IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells, J. Immunol., 154, 799, 10.4049/jimmunol.154.2.799 Fukuda, 1996, Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma, Am. J. Respir. Cell. Mol. Biol., 14, 84, 10.1165/ajrcmb.14.1.8534490 Griffiths-Johnson, 1993, The chemokine, eotaxin, activates guinea-pig eosinophils in vitro, and causes their accumulation into the lung in vivo, Biochem. Biophys. Res. Commun., 197, 1167, 10.1006/bbrc.1993.2599 Jose, 1994, Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation, J. Exp. Med., 179, 881, 10.1084/jem.179.3.881 Baggiolini, 1997, Human chemokines: an update, Ann. Rev. Immunol., 15, 675, 10.1146/annurev.immunol.15.1.675 Jose, 1994, Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs, Biochem. Biophys. Res. Commun., 205, 788, 10.1006/bbrc.1994.2734 Rothenberg, 1995, Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung, J. Exp. Med., 181, 1211, 10.1084/jem.181.3.1211 Rothenberg, 1995, Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression, Proc. Natl. Acad. Sci. U. S. A., 92, 8960, 10.1073/pnas.92.19.8960 Gonzalo, 1996, Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response, Immunity, 4, 1, 10.1016/S1074-7613(00)80293-9 Ishi, 1998, Cloning of rat eotaxin: ozone inhalation increases mRNA and protein expression in lungs of Brown Norway rats, Am. J. Physiol., 274, L171 Ponath, 1996, Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils, J. Clin. Immunol., 97, 604 Garcia-Zepeda, 1996, Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia, Nat. Med., 2, 449, 10.1038/nm0496-449 Kitaura, 1996, Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3., J. Biol. Chem., 271, 7725, 10.1074/jbc.271.13.7725 Forssmann, 1997, Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes, J. Exp. Med., 185, 2171, 10.1084/jem.185.12.2171 White, 1997, Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophil, J. Leukoc. Biol., 62, 667, 10.1002/jlb.62.5.667 Shinkai, 1999, A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils, J. Immunol., 163, 1602, 10.4049/jimmunol.163.3.1602 Elsner, 1996, Human eotaxin represents a potent activator of the respiratory burst of human eosinophils, Eur. J. Immunol., 26, 1919, 10.1002/eji.1830260837 Tenscher, 1996, Recombinant human eotaxin induces oxygen radical production, Ca2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a Pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein, Blood, 88, 3195, 10.1182/blood.V88.8.3195.bloodjournal8883195 Burke-Gaffney, 1996, Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells, Biochem. Biophys. Res. Commun., 227, 35, 10.1006/bbrc.1996.1463 Teixeira, 1997, Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin, J. Clin. Invest., 100, 1657, 10.1172/JCI119690 Sanz, 1998, Human eotaxin induces α4 and β2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4, J. Immunol., 160, 3569, 10.4049/jimmunol.160.7.3569 Palframan, 1998, Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow, Blood, 91, 2240, 10.1182/blood.V91.7.2240 Peled, 1998, The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation, Blood, 91, 1909, 10.1182/blood.V91.6.1909 Quackenbush, 1997, Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse, J. Leukoc. Biol., 62, 661, 10.1002/jlb.62.5.661 Daugherty, 1996, Cloning, expression and characterization of the human eosinophil eotaxin receptor, J. Exp. Med., 183, 2349, 10.1084/jem.183.5.2349 Ponath, 1996, Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils, J. Exp. Med., 183, 2437, 10.1084/jem.183.6.2437 Uguccioni, 1997, High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines, J. Clin. Invest., 100, 1137, 10.1172/JCI119624 Sallusto, 1997, Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells, Science, 277, 2005, 10.1126/science.277.5334.2005 He, 1997, CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia, Nature, 385, 645, 10.1038/385645a0 Choe, 1996, The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates, Cell, 85, 1135, 10.1016/S0092-8674(00)81313-6 Bartels, 1996, Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants, Biochem. Biophys. Res. Commun., 225, 1045, 10.1006/bbrc.1996.1292 Mochizuki, 1998, IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy, J. Immunol., 160, 60, 10.4049/jimmunol.160.1.60 Teran, 1999, Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts, Am. J. Respir. Cell Mol. Biol., 20, 777, 10.1165/ajrcmb.20.4.3508 MacLean, 1996, T cell-dependent regulation of eotaxin in antigen- induced pulmonary eosinophilia, J. Exp. Med., 184, 1461, 10.1084/jem.184.4.1461 Li, 1999, Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells, J. Immunol., 162, 2477, 10.4049/jimmunol.162.5.2477 Zhu, 1999, Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production, J. Clin. Invest., 103, 779, 10.1172/JCI5909 Li, 1998, Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation, J. Immunol., 161, 3128, 10.4049/jimmunol.161.6.3128 Miyamasu, 1999, Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro, Int. Immunol., 11, 1001, 10.1093/intimm/11.6.1001 Gonzalo, 1996, Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines and adhesion receptors, J. Clin. Invest., 98, 2332, 10.1172/JCI119045 Campbell, 1998, Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia, J. Immunol., 161, 7047, 10.4049/jimmunol.161.12.7047 Rothenberg, 1997, Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia, J. Exp. Med., 185, 785, 10.1084/jem.185.4.785 Matthews, 1998, Eotaxin is required for the baseline level of tissue eosinophils, Proc. New York Acad. Sci., 95, 6273, 10.1073/pnas.95.11.6273 Yang, 1998, Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin, Blood, 92, 3912, 10.1182/blood.V92.10.3912 Conroy, 1997, The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation, Mem. Inst. Oswaldo Cruz, 92, 183, 10.1590/S0074-02761997000800024 Ruth, 1998, Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation, J. Immunol., 161, 4276, 10.4049/jimmunol.161.8.4276 Ying, 1997, Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells, Eur. J. Immunol., 27, 3507, 10.1002/eji.1830271252 Mattoli, 1997, Eotaxin expression and eosinophilic inflammation in asthma, Biochem. Biophys. Res. Commun., 236, 299, 10.1006/bbrc.1997.6958 Lamkhioued, 1997, Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation, J. Immunol., 159, 4593, 10.4049/jimmunol.159.9.4593 Minshall, 1997, Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis, Am. J. Respir. Cell Mol. Biol., 17, 683, 10.1165/ajrcmb.17.6.2865 Bartels, 1997, Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression, Rhinology, 35, 171 Teruya-Feldstein, 1999, Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia, Blood, 93, 2463, 10.1182/blood.V93.8.2463 Ying, 1999, J. Immunol., 163, 3976, 10.4049/jimmunol.163.7.3976 Jahnsen, 1999, Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia, J. Immunol., 163, 1545, 10.4049/jimmunol.163.3.1545 Heath, 1997, Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody, J. Clin. Invest., 99, 178, 10.1172/JCI119145